Gen9, Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jul 2014 | $25 M | No. 3 | $10 to $50 million | equity | SEC | |
| Apr 2013 | $21 M | No. 2 | $10 to $50 million | equity | SEC | |
| Aug 2011 | $2 M | No. 1 | Under $2 million | equity, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Gen9, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2014).
SEC Form D · Jul 2014
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jul 2014
That is all the official record says: Gen9, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Gen9, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 43 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| David Stone | Executive officer | Jul 2014 |
| Jennifer Camacho | Executive officer | Jul 2014 |
| Kevin Munnelly | Executive officer | Jul 2014 |
| Aaron Zucker | Executive officer | May 2013 |
| Joseph Jacobson | Mr. Jacobson is the President, Treasurer and Assistant Secretary of the Issuer. | Sep 2011 |
| Lawrence Silverstein | Mr. Silverstein is the Secretary of the Issuer. | Sep 2011 |
| Drew Endy | Director | Jul 2014 |
| Jacob Thaysen | Director | Jul 2014 |
| James Hollenhorst | Director | Jul 2014 |
| Jeremy Wertheimer | Director | Jul 2014 |
| Joseph Jacobson | Director | Jul 2014 |
| Kevin Munnelly | Director | Jul 2014 |
| Neil Cook | Director | Jul 2014 |
| Bill Scalzulli | Director | May 2013 |
| Jim Hollenhorst | Director | May 2013 |
| George Church | Director | Sep 2011 |
| Paul Manning | Director | Sep 2011 |
| Scott Schoen | Director | Sep 2011 |
| Wali Dai | Director | Sep 2011 |
| Drew Endy | Promoter | May 2013 |
| George Church | Promoter | May 2013 |
| Joseph Jacobson | Promoter | May 2013 |